This inventor holds 1 USPTO granted patent. Top assignee: University of Missouri. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations by John Fetse in Cancer Treatment
Introduction
John Fetse is an accomplished inventor based in Mission, KS (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of polypeptides.
Latest Patents
John Fetse holds a patent for "Polypeptides and compositions comprising the same." This patent includes polypeptides that can bind to the human PD-L1 protein. The polypeptides developed by Fetse are designed to block the PD-1/PD-L1 interaction, which is crucial in cancer therapy. He has 1 patent that focuses on methods for treating cancer utilizing these polypeptides and their compositions.
Career Highlights
Fetse is affiliated with the University of Missouri, where he continues to advance his research in the field of biotechnology. His work has the potential to impact cancer treatment significantly, providing new avenues for therapeutic interventions.
Collaborations
John Fetse collaborates with Hao Yu Liu, contributing to the advancement of their shared research goals.
Conclusion
John Fetse's innovative work in developing polypeptides for cancer treatment showcases his dedication to improving healthcare outcomes. His contributions are paving the way for future advancements in cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile